Sequencing IOL choice by eye can ease patient decision paralysis.
Feature|Articles|October 8, 2026
- Ophthalmology Times: September/October 2026
- Volume 51
- Issue 5
Me, myself, and AI: The autonomous cataract practice
Author(s)Oren N. Fass, MD
Fact checked by: Sheryl Stevenson, Nicole Canfora Lupo
A solo surgeon explains how automation replaced his front desk, scheduling, and billing staff.
Advertisement
Advertisement
I run a solo medical and surgical cataract practice without full-time employees. Here is how it works, and why I think it represents an alternative pathway in ophthalmic practice.
Related to this article
The Wilmer Eye Institute's new Glaucoma Division chief discusses mentoring junior faculty, multicenter trials, and optic nerve regeneration.
Host Deborah Ristvedt, DO, welcomes Dr. Mathews to discuss the relationships, passions, and intentional choices that have shaped her career as a cornea, cataract, and refractive surgeon, dry eye expert, and educator.
Three researchers share the prize for discovering channelrhodopsin, a light-sensitive protein now being tested to restore vision in retinal disease.
Cataract original papers on intracameral antibiotics and IOL power, a guideline-based case symposium, and ocular surface sessions headline AAO 2026.
Ashish Sharma, MD, on what real-world data show about switching and long-term outcomes with retinal biosimilars.
Kareem Moussa, MD, discusses how four local corticosteroid injections compare on effectiveness and IOP, and what that means for choosing among them.
Three studies use OCT and OCTA to track AMD treatment response, flag diabetic retinopathy before oedema and confirm ocular toxoplasmosis.
Advertisement
Advertisement